長期投資家のためのIR情報
バリュートレンド

【4527】ロート製薬
目薬(一般用医薬品)
類似企業:
【業界1位】 小野薬品工業
【売上同水準】 協和キリン 参天製薬

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.03 2026/08/06 Q1予 372,300 ↑ +0.8% +0.8% 45,000 ↑ +2.7% +2.7% 47,400 ↑ +2.8% +2.8% 35,200 ↑ +2.0% +2.0%
2027.03 2026/05/13 当初予 369,500 - - - 43,800 - - - 46,100 - - - 34,500 - - -
2026.03 2026/05/13 実 343,725 ↑ +0.9% +2.8% 41,118 ↑ +1.5% +5.4% 47,971 ↑ +3.2% +18.4% 34,247 ↑ +3.8% +10.1%
2026.03 2026/02/12 Q3予 340,500 ↑ +0.6% +1.8% 40,500 ↑ +2.5% +3.8% 46,500 ↑ +5.7% +14.8% 33,000 ↑ +3.1% +6.1%
2026.03 2025/11/13 Q2予 338,500 ↑ +1.2% +1.2% 39,500 ↑ +1.3% +1.3% 44,000 ↑ +2.3% +8.6% 32,000 ↑ +1.6% +2.9%
2026.03 2025/08/06 Q1予 334,500 → 0.0% 0.0% 39,000 → 0.0% 0.0% 43,000 ↑ +6.2% +6.2% 31,500 ↑ +1.3% +1.3%
2026.03 2025/05/13 当初予 334,500 - - - 39,000 - - - 40,500 - - - 31,100 - - -
2025.03 2025/05/13 実 308,625 ↓ -3.6% +2.9% 38,939 ↓ -9.9% -9.4% 40,430 ↓ -8.5% -8.1% 31,006 ↓ -3.7% -3.1%
2025.03 2025/02/12 Q3予 320,000 → 0.0% +6.7% 43,200 → 0.0% +0.5% 44,200 → 0.0% +0.5% 32,200 → 0.0% +0.6%
2025.03 2024/11/13 Q2予 320,000 → 0.0% +6.7% 43,200 → 0.0% +0.5% 44,200 → 0.0% +0.5% 32,200 → 0.0% +0.6%
2025.03 2024/08/07 Q1予 320,000 ↑ +6.7% +6.7% 43,200 ↑ +0.5% +0.5% 44,200 ↑ +0.5% +0.5% 32,200 ↑ +0.6% +0.6%
2025.03 2024/05/13 当初予 300,000 - - - 43,000 - - - 44,000 - - - 32,000 - - -
2024.03 2024/05/13 実 270,840 ↓ -0.4% +4.6% 40,048 ↑ +0.1% +14.4% 42,434 ↑ +2.3% +17.9% 30,936 ↑ +3.1% +16.7%
2024.03 2024/02/09 Q3予 272,000 ↑ +0.7% +5.0% 40,000 ↑ +3.9% +14.3% 41,500 ↑ +3.8% +15.3% 30,000 ↑ +3.4% +13.2%
2024.03 2023/11/10 Q2予 270,000 ↑ +2.7% +4.2% 38,500 ↑ +4.1% +10.0% 40,000 ↑ +5.3% +11.1% 29,000 ↑ +5.5% +9.4%
2024.03 2023/08/09 Q1予 263,000 ↑ +1.5% +1.5% 37,000 ↑ +5.7% +5.7% 38,000 ↑ +5.6% +5.6% 27,500 ↑ +3.8% +3.8%
2024.03 2023/05/12 当初予 259,000 - - - 35,000 - - - 36,000 - - - 26,500 - - -
2023.03 2023/05/12 実 238,664 ↑ +1.1% +9.5% 33,959 ↑ +2.9% +21.3% 35,568 ↑ +7.8% +27.0% 26,377 ↑ +9.9% +35.3%
2023.03 2023/02/13 Q3予 236,000 ↑ +2.6% +8.3% 33,000 ↑ +6.5% +17.9% 33,000 ↑ +3.1% +17.9% 24,000 ↑ +9.1% +23.1%
2023.03 2022/11/10 Q2予 230,000 ↑ +2.2% +5.5% 31,000 ↑ +3.3% +10.7% 32,000 ↑ +3.2% +14.3% 22,000 ↑ +2.3% +12.8%
2023.03 2022/08/09 Q1予 225,000 ↑ +3.2% +3.2% 30,000 ↑ +7.1% +7.1% 31,000 ↑ +10.7% +10.7% 21,500 ↑ +10.3% +10.3%
2023.03 2022/05/12 当初予 218,000 - - - 28,000 - - - 28,000 - - - 19,500 - - -
2022.03 2022/05/12 実 199,646 ↑ +2.4% +9.7% 29,349 ↑ +4.8% +27.1% 29,084 ↑ +3.9% +21.7% 21,018 ↑ +7.8% +22.9%
2022.03 2022/02/10 Q3予 195,000 ↑ +2.6% +7.1% 28,000 ↑ +12.0% +21.2% 28,000 ↑ +12.0% +17.2% 19,500 ↑ +8.3% +14.0%
2022.03 2021/11/11 Q2予 190,000 ↑ +4.4% +4.4% 25,000 ↑ +8.2% +8.2% 25,000 ↑ +4.6% +4.6% 18,000 ↑ +5.3% +5.3%
2022.03 2021/08/10 Q1予 182,000 → 0.0% 0.0% 23,100 → 0.0% 0.0% 23,900 → 0.0% 0.0% 17,100 → 0.0% 0.0%
2022.03 2021/05/12 当初予 182,000 - - - 23,100 - - - 23,900 - - - 17,100 - - -
2021.03 2021/05/12 実 181,287 ↓ -0.9% -0.9% 22,990 ↑ +5.5% +5.5% 23,910 ↑ +8.2% +8.2% 16,743 ↑ +19.6% +19.6%
2021.03 2021/02/10 Q3予 183,000 → 0.0% 0.0% 21,800 → 0.0% 0.0% 22,100 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2021.03 2020/11/12 Q2予 183,000 → 0.0% 0.0% 21,800 → 0.0% 0.0% 22,100 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2021.03 2020/08/11 Q1予 183,000 → 0.0% 0.0% 21,800 → 0.0% 0.0% 22,100 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2021.03 2020/05/12 当初予 183,000 - - - 21,800 - - - 22,100 - - - 14,000 - - -
2020.03 2020/05/12 実 188,327 ↑ +2.4% +2.4% 23,085 ↑ +7.4% +7.4% 22,735 ↑ +6.7% +6.7% 15,410 ↑ +14.1% +14.1%
2020.03 2020/02/12 Q3予 184,000 → 0.0% 0.0% 21,500 → 0.0% 0.0% 21,300 → 0.0% 0.0% 13,500 → 0.0% 0.0%
2020.03 2019/11/13 Q2予 184,000 → 0.0% 0.0% 21,500 → 0.0% 0.0% 21,300 → 0.0% 0.0% 13,500 → 0.0% 0.0%
2020.03 2019/08/08 Q1予 184,000 → 0.0% 0.0% 21,500 → 0.0% 0.0% 21,300 → 0.0% 0.0% 13,500 → 0.0% 0.0%
2020.03 2019/05/10 当初予 184,000 - - - 21,500 - - - 21,300 - - - 13,500 - - -
2019.03 2019/05/10 実 183,582 ↑ +0.2% +4.3% 20,812 ↓ -2.7% +6.7% 18,970 ↓ -13.0% -3.2% 9,799 ↓ -26.3% -17.7%
2019.03 2019/02/13 Q3予 183,300 → 0.0% +4.1% 21,400 → 0.0% +9.7% 21,800 → 0.0% +11.2% 13,300 → 0.0% +11.8%
2019.03 2018/11/13 Q2予 183,300 ↑ +4.1% +4.1% 21,400 ↑ +9.7% +9.7% 21,800 ↑ +11.2% +11.2% 13,300 ↑ +11.8% +11.8%
2019.03 2018/08/09 Q1予 176,000 → 0.0% 0.0% 19,500 → 0.0% 0.0% 19,600 → 0.0% 0.0% 11,900 → 0.0% 0.0%
2019.03 2018/05/11 当初予 176,000 - - - 19,500 - - - 19,600 - - - 11,900 - - -
2018.03 2018/05/11 実 171,742 ↑ +4.1% +8.4% 19,087 ↑ +13.6% +22.4% 18,849 ↑ +11.5% +17.8% 9,289 ↓ -11.5% -8.9%
2018.03 2018/02/09 Q3予 165,000 → 0.0% +4.1% 16,800 → 0.0% +7.7% 16,900 → 0.0% +5.6% 10,500 → 0.0% +2.9%
2018.03 2017/11/10 Q2予 165,000 → 0.0% +4.1% 16,800 ↑ +7.7% +7.7% 16,900 → 0.0% +5.6% 10,500 → 0.0% +2.9%
2018.03 2017/11/02 修正予 165,000 ↑ +4.1% +4.1% - - - - 16,900 ↑ +5.6% +5.6% 10,500 ↑ +2.9% +2.9%
2018.03 2017/08/08 Q1予 158,500 → 0.0% 0.0% 15,600 → 0.0% 0.0% 16,000 → 0.0% 0.0% 10,200 → 0.0% 0.0%
2018.03 2017/05/11 当初予 158,500 - - - 15,600 - - - 16,000 - - - 10,200 - - -
2017.03 2017/05/11 実 154,599 ↓ 0.0% -5.2% 15,451 ↓ -0.3% -0.3% 15,964 ↑ +3.0% +5.0% 10,011 ↑ +0.1% +5.4%
2017.03 2017/04/28 修正予 154,600 ↑ +2.7% -5.2% 15,500 ↑ +18.3% 0.0% 15,500 ↑ +15.7% +2.0% 10,000 ↑ +33.3% +5.3%
2017.03 2017/02/08 Q3予 150,500 → 0.0% -7.7% 13,100 → 0.0% -15.5% 13,400 → 0.0% -11.8% 7,500 → 0.0% -21.1%
2017.03 2016/11/11 Q2予 150,500 ↓ -7.7% -7.7% 13,100 ↓ -15.5% -15.5% 13,400 ↓ -11.8% -11.8% 7,500 ↓ -21.1% -21.1%
2017.03 2016/05/13 当初予 163,000 - - - 15,500 - - - 15,200 - - - 9,500 - - -
2016.03 2016/05/13 実 167,016 ↓ -0.3% +1.8% 15,683 ↑ +3.9% +14.5% 15,339 ↑ +1.6% +8.8% 9,098 ↓ -4.2% +3.4%
2016.03 2016/02/09 Q3予 167,500 → 0.0% +2.1% 15,100 → 0.0% +10.2% 15,100 → 0.0% +7.1% 9,500 → 0.0% +8.0%
2016.03 2015/11/11 Q2予 167,500 → 0.0% +2.1% 15,100 → 0.0% +10.2% 15,100 → 0.0% +7.1% 9,500 → 0.0% +8.0%
2016.03 2015/11/04 修正予 167,500 ↑ +2.1% +2.1% 15,100 ↑ +10.2% +10.2% 15,100 ↑ +7.1% +7.1% 9,500 ↑ +8.0% +8.0%
2016.03 2015/08/06 Q1予 164,000 → 0.0% 0.0% 13,700 → 0.0% 0.0% 14,100 → 0.0% 0.0% 8,800 → 0.0% 0.0%
2016.03 2015/05/14 当初予 164,000 - - - 13,700 - - - 14,100 - - - 8,800 - - -
2015.03 2015/05/14 実 151,774 ↓ -0.1% -0.1% 13,159 ↓ -6.0% -22.6% 14,098 ↓ -2.8% -18.0% 8,631 ↓ -4.1% -18.6%
2015.03 2015/02/06 Q3予 152,000 → 0.0% 0.0% 14,000 ↓ -9.7% -17.6% 14,500 ↓ -9.4% -15.7% 9,000 ↓ -10.0% -15.1%
2015.03 2014/11/11 Q2予 152,000 → 0.0% 0.0% 15,500 ↓ -8.8% -8.8% 16,000 ↓ -3.0% -7.0% 10,000 ↓ -1.0% -5.7%
2015.03 2014/08/07 Q1予 152,000 → 0.0% 0.0% - - - - 16,500 ↓ -4.1% -4.1% 10,100 ↓ -4.7% -4.7%
2015.03 2014/05/14 当初予 152,000 - - - 17,000 - - - 17,200 - - - 10,600 - - -
2014.03 2014/05/14 実 143,822 ↑ +0.0% +0.0% 16,821 ↑ +0.1% +0.1% 17,100 → 0.0% 0.0% 8,947 ↓ -0.6% -0.6%
2014.03 2014/05/12 当初予 143,800 - - - 16,800 - - - 17,100 - - - 9,000 - - -
シェア ツイート
ページトップへ戻る